Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Seventy-flavor Turquoise Pills (Qishiweisongshi Wan) is a traditional Tibetan medicine developed and marketed by Qinghai Jiumei Tibetan Medicine. It is a complex multi-ingredient oral formulation composed of seventy different ingredients, including various herbs and minerals. The medicine is primarily indicated for the treatment of liver and gallbladder disorders, such as early liver cirrhosis, ascites, fatty liver, acute and chronic hepatitis, and cholecystitis. Pharmacologically, it is described as functioning to clear heat, detoxify, soothe the liver, benefit the gallbladder, and resolve blood stasis. It is specifically designed to address symptoms related to liver qi stagnation and damp-heat blood stasis, including chest and rib distension, vomiting, hiccups, and loss of appetite. While it is a widely used traditional medicine with a national drug approval number in China, its specific molecular targets and biological mechanisms have not been fully characterized using modern pharmacological methods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Seventy-flavor Turquoise Pills.